EDGAR Filing Documents for 0001144204-05-024399

Form 10QSB - Optional form for quarterly and transition reports of small business issuers:

SEC Accession No. 0001144204-05-024399

Filing Date

2005-08-10

Accepted

2005-08-10 10:23:31

Documents

Period of Report

2005-06-30

Document Format Files

Seq	Description	Document	Type	Size
1		v023340_10qsb.txt	10QSB	122364
2		v023340_ex10-18.txt	EX-10.18	7179
3		v023340_ex10-19.txt	EX-10.19	64345
4		v023340_ex31-1.txt	EX-31.1	3374
5		v023340_ex31-2.txt	EX-31.2	3578
6		v023340_ex32-1.txt	EX-32.1	1374
7		v023340_ex32-2.txt	EX-32.2	1353
	Complete submission text file	0001144204-05-024399.txt		205198

Mailing Address 1350 AVENUE OF THE AMERICAS NEW YORK NY 10019

Business Address 1350 AVENUE OF THE AMERICAS NEW YORK NY 10019 250-519-0553

BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 0331
Type: 10QSB | Act: 34 | File No.: 333-61610 | Film No.: 051012145
SIC: 2836 Biological Products, (No Diagnostic Substances)